|
TXLNA expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.228300E-04 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.896500E-03 |
| Normal-vs-Stage2 |
1.276080E-02 |
| Normal-vs-Stage3 |
7.296600E-03 |
| Normal-vs-Stage4 |
4.123300E-03 |
| Stage1-vs-Stage2 |
4.646800E-01 |
| Stage1-vs-Stage3 |
7.998400E-01 |
| Stage1-vs-Stage4 |
5.154000E-01 |
| Stage2-vs-Stage3 |
6.026200E-01 |
| Stage2-vs-Stage4 |
9.236600E-01 |
| Stage3-vs-Stage4 |
6.501400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.990800E-04 |
| Normal-vs-AfricanAmerican |
2.021300E-03 |
| Normal-vs-Asian |
1.104190E-03 |
| Caucasian-vs-AfricanAmerican |
3.274200E-01 |
| Caucasian-vs-Asian |
3.787800E-01 |
| AfricanAmerican-vs-Asian |
7.508800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.655600E-03 |
| Normal-vs-Female |
7.043600E-04 |
| Male-vs-Female |
7.808000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.498900E-03 |
| Normal-vs-Age(41-60Yrs) |
7.013400E-04 |
| Normal-vs-Age(61-80Yrs) |
2.634100E-02 |
| Normal-vs-Age(81-100Yrs) |
1.763400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.933200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.456800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.342200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.545600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.026000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.219200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.066600E-01 |
| Classical-VS-Follicular |
4.389900E-04 |
| Classical-VS-Other |
1.278060E-02 |
| Classical-VS-Normal |
1.69345999999626E-05 |
| Tall-VS-Follicular |
2.688200E-01 |
| Tall-VS-Other |
5.499800E-02 |
| Tall-VS-Normal |
4.372300E-02 |
| Follicular-VS-Other |
2.795600E-01 |
| Follicular-VS-Normal |
4.241000E-01 |
| Other-VS-Normal |
3.007800E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.922380E-03 |
| Normal-vs-N1 |
5.504000E-01 |
| N0-vs-N1 |
5.700200E-02 |
|
|
